JNJ

Quote

Short

News

Articles

Message Board

BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway

May 22, 2026 10:27:44 am

Source: SeekingAlpha

2026-05-22 10:27:44 ET

Written by Nick Ackerman, co-produced by Stanford Chemist ...

Read the full article on Seeking Alpha

For further details see:

BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway

Johnson & Johnson

NASDAQ: JNJ

JNJ Trading

2.88% G/L:

$234.135 Last:

3,340,249 Volume:

$230 Open:

COSM Ad 300

JNJ Latest News

June 04, 2026 09:28:14 am

Investors Are Watching This High-Stakes Corner of Biotech

June 03, 2026 12:25:00 pm

1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't

June 03, 2026 12:04:00 am

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

June 03, 2026 12:03:00 am

Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren's disease

JNJ Stock Data

Market Cap $577,845,337,264

Float 2,385,202,151

Insiders Ownership 0.01%

Institutions 2802

Short Percent N/A

Industry Pharmaceuticals

Sector Healthcare

Website https://www.jnj.com

Country US

City New Brunswick

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App